Skip to main content
TipRanks
Go Ultimate75% OFF

Medigen Biotechnology Corporation (3176) Q2 2025 Earnings Report

TW:3176 Q2 2025 EPS Results

Actual EPS
-TWD 0.27
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
TWD 0.09

TW:3176 Q2 2025 Revenue Results

Actual Revenue
TWD 362.06M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+2.25%

Earnings Announcement Details

Quarter
Q2 2025
Date
08/11/2025
Time
TBA
Conference Call
Monday, August 11, 2025

Q2 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:3176 Earnings History

TW:3176 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20262026 (Q3)―-0.07-0.4182.22% (+0.33)
Aug 11, 20262026 (Q2)―-0.19-0.2731.87% (+0.09)
Mar 11, 20262025 (Q4)―-0.84-0.82-2.44% (-0.02)
Nov 10, 20252025 (Q3)―-0.41-0.19-109.84% (-0.21)
Aug 11, 20252025 (Q2)―-0.270.09-417.44% (-0.36)
May 12, 20252025 (Q1)―0.73-0.54235.11% (+1.28)
Mar 10, 20252024 (Q4)―-0.82-2.3164.62% (+1.49)
Nov 14, 20242024 (Q3)―-0.19-0.3443.07% (+0.15)
Aug 29, 20242024 (Q2)―0.09-0.7112.29% (+0.79)
May 15, 20242024 (Q1)―-0.54-0.6820.00% (+0.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed